Švejk je jen jeden. Naštěstí

Mgr. Iva Daňková

Psychiatr. pro Praxi, 2007; 1: 3  

Co ještě nevíme o bipolární poruše?

prof. MUDr. Eva Češková CSc

Psychiatr. pro Praxi, 2007; 1: 9-12  

With the advent of randomized clinical trials to prove efficacy for psychiatric treatment, it was necessary to devise methods to measure clinical outcomes and conceptualize remission also in bipolar disorder. At the beggining comorbidity and gender differences in course of the illness are discussed. Further this article details the pharmacotherapy. At first general recommendation for the treatment of bipolar disorder and criteria for individual choice are summarized. Recent views on treatment of mania, bipolar depression and maintenance treatment are reviewed. Finally the side effects problematic during maintenance treatment are mentioned. In near...

TREATMENT OF DEPRESSION WITH ANXIETY AND INSOMNIA

MUDr. Jiřina Kosová

Psychiatr. pro Praxi, 2007; 1: 13-16  

Mixed symptomatology worsens therapy compliance and response to treatment strategy, tapers off chances for achievement of full remission, increases risk of suicidal behavior. These situations thus require grounding of a different treatment plan, thinking over of additional procedures, re-evaluation of selection of drugs and their dosing. Psychotherapy and pharmacology as well, are both efficacious in treatment of isolated disorders; however combination of treatments could be more effective. This is why we strive to employ combination of remedies also in the treatment of comorbid disorders. The key aim of the treatment must be always achievement of...

Advances in diagnosis of Alzheimer’s disease

MUDr. Aleš Bartoš Ph.D, RNDr. Daniela Řípová CSc

Psychiatr. pro Praxi, 2007; 1: 17-21  

New neuropsychological facts supporting long preclinical phase of Alzheimer’s disease are reviewed in the article. Simple cognitive tests provide tools to use novel information. Furthermore options and trends in neurochemical diagnosis of Alzheimer’s disease using protein triplet beta-amyloid, tau protein and phosphotau protein from cerebrospinal fluid are summarized.

EPIDEMIOLOGY AND PSYCHIATRY

prof. MUDr. Vladimír Janout CSc, prof. MUDr. Jaroslav Bouček CSc

Psychiatr. pro Praxi, 2007; 1: 22-26  

The relationship between epidemiology and psychiatry is presented. Clinical epidemiology, being the basis for Evidence Based Medicine, is emphasized and basic designs of epidemiologic studies are described with examples from psychiatry. Specific problems of psychiatric epidemiology are also discussed.

ORGANIC PERSONALITY DISORDERS

doc. MUDr. Roman Jirák CSc

Psychiatr. pro Praxi, 2007; 1: 27-28  

Organic personality disorder is an infrequently diagnosed entity that is in reality more common. Organic factors may significantly influence personality structure. Various clinical presentations are discussed and various types of personality disorder are classified according their prevailing symptoms. Further on we discuss the most frequent localization of lesions responsible for organic personality disorder as well as their most frequent causes. Cerebrovascular factors, trauma consequences, infections and central nervous intoxications, epilepsy, status post neurosurgical interventions belong to the most frequent causes. Some organic disorders are...

Contemporary view on child and adolescent depression

MUDr. Iva Dudová

Psychiatr. pro Praxi, 2007; 1: 29-31  

An overview article deals with child and adolescent form of depressive disorder. Juvenile depression is a severe recurrent disorder with social consequences often leading to social isolation. Suicide risk is substantially increased. Diagnostics and treatment of juvenile depression is more difficult than in adult depression. A brief overview of classification, epidemiology, etiology, differential diagnostics, course, and prognosis is given. Differences in clinical pictures of preschool, school and adolescent depression are described. High frequency of comorbid diagnoses in juvenile depression is mentioned, with an example of comorbidity of depression...

CRAVING IN ADDICTIVE DISEASES - ITS IMPORTANCE AND TREATMENT

MUDr. Karel Nešpor CSc

Psychiatr. pro Praxi, 2007; 1: 32-34  

Psychological and pharmacological approaches to deal with craving in addictive diseases are reviewed. Psychological methods should be simple and deeply imprinted to be applicable even when cognitive functions are temporarily impaired by stress and/or craving.

Demence - etiopatogenetické faktory v praxi

MUDr. Helena Kučerová HonDG

Psychiatr. pro Praxi, 2007; 1: 35-37  

Výskyt sexuálních dysfunkcí při udržovací léčbě běžně předepisovanými antidepresivy

MUDr. Alexandra Žourková CSc, MUDr. Jana Novotná, MUDr. Pavla Havlíková, Monika Večeřová, MUDr. Lucie Purkrábková

Psychiatr. pro Praxi, 2007; 1: 38-41  

Psychoterapie deprese

MUDr. Michal Kryl

Psychiatr. pro Praxi, 2007; 1: 42-43  

Jak (ne)měřit kognitivní funkce

PhDr. Marek Preiss

Psychiatr. pro Praxi, 2007; 1: 44-45